Delivery Order SPE2DE23D0008-SPE2D626F608C
- Not listed
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $1,495.00 on September 2, 2025, for the supply of Natrelle TE Smooth 133S-MX-13-T breast implants. This fixed-price contract with economic price adjustment is funded by the Medical Supply Chain division of the Defense Logistics Agency Troop Support Medical and is scheduled for completion by September 4, 2025. The contract carries no set-aside designation, reflecting Allergan's status as a sole-source...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,495 fixed-price delivery order for NATRELLE TE Smooth 133S-MX-15-T breast implants on August 14, 2025, with an ultimate completion date of August 18, 2025. This contract was funded by the Medical Supply Chain division of the Defense Logistics Agency and will be performed in Irvine, California. The award carries no set-aside designation, reflecting Allergan's status as a sole-source provider of specialized breast implant...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $2,990.00 for Natrelle TE Smooth 133S-MV-14-T breast implants under a fixed-price contract with economic price adjustment. The award was issued on September 11, 2025, with an ultimate completion date of September 25, 2025, and carries no set-aside designation, reflecting Allergan's status as a sole-source provider of these specialized medical devices. The product will be delivered to Irvine, California,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $23,920 by the Defense Logistics Agency's Medical Supply Chain division on December 12, 2025, for Natrelle TE Smooth 133S-FV-12-T breast implants. The contract is structured as a fixed-price agreement with economic price adjustment and carries an ultimate completion date of December 16, 2025. The award was made without a set-aside designation, reflecting Allergan's status as a sole-source provider of these...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,990 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on July 10, 2025, for Natrelle TE Smooth 133S breast implants. This delivery order, which carries an ultimate completion date of July 28, 2025, represents a child award under one of Allergan's two significant Indefinite Delivery Vehicle contracts established with DLA Troop Support Medical on December 8, 2022. The award was made without...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,495.00 fixed-price delivery order to Allergan USA Inc. for Natrelle TE Smooth 133S breast implants on November 20, 2025, with a completion date of November 24, 2025. This delivery order is a child contract issued under one of Allergan's two larger Indefinite Delivery/Indefinite Quantity agreements with DLA Troop Support Medical, specifically the $13.5 million IDV for Natrelle breast implants and surgical devices established in...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,614.00 fixed-price delivery order on September 19, 2025, for Natrelle Inspira SCM 445CC breast implants through the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract carries an ultimate completion date of September 23, 2025, and will be performed in Irvine, California. This delivery order was issued without set-aside designation, reflecting Allergan's sole-source supplier status for specialized...
- Allergan USA Inc., a subsidiary of Abbvie Inc., has been awarded a $1,495 fixed-price delivery order by the Defense Logistics Agency Troop Support Medical for NATRELLE TE SMOOTH 133S-MX-14-T breast implants. The contract has no set-aside designation and calls for Allergan to provide the proprietary breast implants for reconstructive procedures, with performance taking place at Allergan's Irvine, California facility. Allergan additionally maintains several vehicles with the Agency, including a...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,021.00 fixed-price delivery order with economic price adjustment for Natrelle Inspira SCM 375CC breast implants on July 22, 2025. This delivery order, which is a child contract under a larger Indefinite Delivery Vehicle, will be performed in Irvine, California and is scheduled for completion by July 24, 2025. The contract was awarded without set-aside designation by the Medical Supply Chain division of the Defense Logistics...
- Allergan USA Inc., a subsidiary of Abbvie Inc., has been awarded a $1,495 fixed-price delivery order by the Defense Logistics Agency Troop Support Medical to supply NATRELLE TE SMOOTH 133S-MX-13-T breast implants for reconstructive procedures. Performance will occur at Allergan's facility in Irvine, California, with completion by December 2023. The award was issued utilizing a $13.5 million Indefinite Delivery Vehicle with the Defense Logistics Agency Troop Support Medical that facilitates...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D626F608CDelivery Order
Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,495.00 fixed-price delivery order for Natrelle TE Smooth 133S-MX-15-T breast implants on December 1, 2025, with an ultimate completion date of December 3, 2025. The contract was issued without a set-aside designation and represents a child order under one of Allergan's existing Indefinite Delivery/Indefinite Quantity (IDV) contracts with the Defense Logistics Agency Troop Support Medical. The place of performance is Irvine, California. Funding was provided by the Medical Supply Chain division of the Defense Logistics Agency, which operates under the Department of Defense. This delivery order supports reconstructive and aesthetic surgical procedures at military treatment facilities, Veterans Affairs hospitals, and Indian Health Service centers. Allergan holds two significant IDV contracts with DLA Troop Support Medical—a $4.9 million contract for Allergan Aesthetics surgical items and a $13.5 million contract for Natrelle breast implants and related devices, both established on December 8, 2022. These IDVs enable electronic ordering and fulfillment of specialized surgical products across Department of Defense research centers and clinics, with Allergan positioned as the sole-source provider of these critical medical devices for federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/30/25 |